AHS 2021 consensus on integrating new migraine therapies into clinical practice: Isn’t our goal choice of best therapy regardless of cost?

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Headache 2022-01, Vol.62 (1), p.109-110
Hauptverfasser:	Charles, James A., Turner, Ira M.
Format:	Artikel
Sprache:	eng
Schlagworte:	abortives Antibodies, Monoclonal - economics Antibodies, Monoclonal - therapeutic use Calcitonin Gene-Related Peptide - immunology Calcitonin Gene-Related Peptide Receptor Antagonists - economics Calcitonin Gene-Related Peptide Receptor Antagonists - therapeutic use choice of therapy Consensus Drug Prescriptions - economics Drug Prescriptions - standards Headache Humans Migraine Migraine Disorders - drug therapy Migraine Disorders - economics Migraine Disorders - prevention & control preventives Societies, Medical - standards
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!